Skip to main content
. 2021 Mar 24;6(5):522–531. doi: 10.1001/jamacardio.2021.0372

Table 2. Change in Scores From Baseline to 12 Months by Change in NYHA Class.

Change Worsening of ≥2 classes (n = 34) Worsening of 1 class (n = 369) No change (n = 1870) Improvement of 1 class (n = 520) Improvement of ≥2 classes (n = 79)
KCCQ, median (IQR)
OS 2 (−24 to 9) 1 (−11 to 11) 3 (−6 to 16) 8 (−1 to 19) 11 (0 to 31)
CSS −5 (−22 to 9) 0 (−13 to 11) 3 (−7 to 16) 6 (−2 to 21) 8 (−1 to 27)
PLS −8 (−17 to 8) 0 (−17 to 17) 0 (−8 to 17) 8 (0 to 25) 17 (0 to 42)
SFS −8 (−25 to 10) 0 (−17 to 12) 0 (−8 to 15) 6 (−4 to 21) 8 (−4 to 25)
EQ-5D, median (IQR)
VAS −4 (−11 to 8) 0 (−11 to 10) 0 (−10 to 10) 3 (−6 to 14) 0 (−9 to 11)
Index −0.05 (−0.13 to 0.04) −0.01 (−0.12 to 0.04) 0.00 (−0.06 to 0.09) 0.01 (−0.03 to 0.13) 0.03 (−0.01 to 0.14)

Abbreviations: EQ-5D, EuroQoL 5-dimension; IQR, interquartile range; KCCQ-CSS, Kansas City Cardiomyopathy Questionnaire Clinical Summary Score; KCCQ-OS, Kansas City Cardiomyopathy Questionnaire Overall Summary Score; KCCQ-PLS, Kansas City Cardiomyopathy Questionnaire Physical Limitation Score; KCCQ-SFS, Kansas City Cardiomyopathy Questionnaire Symptom Frequency Score; NYHA, New York Heart Association; VAS, visual analog scale.